World's Best Scientists 2026 revealed!
Pharmacoepidemiology and Drug Safety
H-index 25

Pharmacoepidemiology and Drug Safety

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 979 238 338 23

Additional Metrics

Number of Best Scientists*: 324
Documents by Best Scientists*: 399
Top 100 Ranked Scientists*: 6
SCIMAGO H-index: 113
SCIMAGO SJR: 1.022
Impact Factor: 2.4

Overview

Top Research Topics at Pharmacoepidemiology and Drug Safety?

The primary areas of discussion in Pharmacoepidemiology and Drug Safety are Pharmacoepidemiology, Internal medicine, Medical prescription, Pediatrics and Family medicine. While Pharmacoepidemiology is the focus of Pharmacoepidemiology and Drug Safety, it also provided insights into the studies of Retrospective cohort study, Adverse effect, Pharmacovigilance and Emergency medicine. Pharmacoepidemiology and Drug Safety dives deep in exploring the relationship between the study of Internal medicine and Surgery.

The journal explores topics in Medical prescription which can be helpful for research in disciplines like Pharmacy and Psychiatry. The study on Pediatrics presented in Pharmacoepidemiology and Drug Safety intersects with subjects under the field of Incidence (epidemiology). While it focused on Family medicine, it was also able to explore topics like Alternative medicine and MEDLINE.

The journal explores issues in Cohort study which can be linked to other research areas like Proportional hazards model and Hazard ratio. Drug is a focus of the presented Pharmacology works and it dives deep in Drug. The research on Odds ratio discussed in Pharmacoepidemiology and Drug Safety draws on the closely related field of Case-control study.

  • Pharmacoepidemiology (27.64%)
  • Internal medicine (27.55%)
  • Medical prescription (16.66%)

What are the most cited papers published in the journal?

  • The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months (1098 citations)
  • Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. (975 citations)
  • Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports (760 citations)

Research areas of the most cited articles at Pharmacoepidemiology and Drug Safety:

The published papers focus largely on the fields of Internal medicine, MEDLINE, Pharmacoepidemiology, Medical prescription and Pediatrics. The journal articles focus on Internal medicine but the discussions also offer insight into other areas such as Surgery and Pharmacology. While Pharmacoepidemiology is the key highlight in the journal publications, thet also covered some subjects on Confounding and Observational study.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Diabetes mellitus

The previous edition focused in particular on these issues:

The objective of Pharmacoepidemiology and Drug Safety is to combine knowledge in the areas of Internal medicine, Pharmacoepidemiology, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 2019-20 coronavirus outbreak. The Internal medicine research presented places emphasis on topics like Cohort, Confidence interval, Cohort study, Retrospective cohort study and Hazard ratio. The journal explores the study of Pharmacoepidemiology to improve our understanding of the broader topic of Medical prescription.

Health care and Opioid are some topics wherein Medical prescription research discussed in Pharmacoepidemiology and Drug Safety have an impact. The journal focuses on Coronavirus disease 2019 (COVID-19) as well as the interrelated topic of Medical emergency. The presented research on Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) deals specifically with Emergency medicine but it also addresses topics in Adverse effect.

The most cited articles from the last journal are:

  • Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology. (5 citations)
  • Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom (4 citations)
  • Knowledge and practices towards COVID-19 during its outbreak: A multinational cross-sectional study (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Pharmacoepidemiology and Drug Safety (based on the number of publications) are:

  • Olaf H. Klungel (115 papers) published 6 papers at the last edition, 2 more than at the previous edition,
  • Anton Pottegård (69 papers) published 7 papers at the last edition, 6 less than at the previous edition,
  • Brian L. Strom (64 papers) published 3 papers at the last edition,
  • Jesper Hallas (64 papers) published 7 papers at the last edition, 8 less than at the previous edition,
  • Anthonius de Boer (57 papers) published 2 papers at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Pharmacoepidemiology and Drug Safety (based on the number of publications) are:

  • Harvard University (259 papers) published 21 papers at the last edition, 1 more than at the previous edition,
  • Brigham and Women's Hospital (188 papers) published 12 papers at the last edition, 9 less than at the previous edition,
  • University of Pennsylvania (174 papers) published 11 papers at the last edition, 6 more than at the previous edition,
  • Utrecht University (150 papers) published 9 papers at the last edition the same number as at the previous edition,
  • Kaiser Permanente (137 papers) published 14 papers at the last edition, 8 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 32.79% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 37.56% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.71% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.22% of all publications and 39.51% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Pharmacology and Research

While academically enriching, the field of Pharmacoepidemiology and Drug Safety also offers numerous career opportunities. Individuals with a background in this area can apply their skills and knowledge in various professional roles, such as academia, pharmaceutical companies, government agencies, and contract research organizations.

One such opportunity is the role of a Registered Nurse, which involves direct patient care and encompasses different branches, including emergency, surgical, pediatric, and family medicine. Moreover, pharmacology knowledge is crucial in this role due to drug administration and prescription aspects. However, to practice as a Registered Nurse, one must meet specific licensure requirements. For instance, to learn more about the licensing process in Maryland, visit our page on maryland nursing license requirements.

Other roles include Clinical Research Associates, Data Managers, Regulatory Affairs Managers, and Pharmacokineticists among others. These careers require a deep understanding of pharmacology principles, drug safety practices, and regulatory guidelines. They often allow the individual to contribute to public health and safety directly, ensuring safe and effective use of medications.

Regardless of the chosen career path, obtaining a strong foundation in Pharmacoepidemiology and Drug Safety will undoubtedly provide beneficial career prospects. Continuous education, learning, and research in this field will allow individuals to stay updated with the latest developments and improve patient care.

Top Publications

  • Time-related biases in pharmacoepidemiology.

    Samy Suissa;Samy Suissa;Sophie Dell'Aniello

    (2020)
    98 Citations
  • Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators

    (2022)
    89 Citations
  • Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products

    (2022)
    86 Citations
  • HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force

    (2022)
    66 Citations
  • Accuracy of Japanese claims data in identifying diabetes‐related complications

    Kazuya Fujihara;Mayuko Yamada-Harada;Yasuhiro Matsubayashi;Masaru Kitazawa

    (2021)
    64 Citations
  • Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative.

    Lucinda S. Orsini;Brigitta Monz;C. Daniel Mullins;David Van Brunt

    (2020)
    54 Citations
  • Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden

    Gabriella Bröms;Helle Kieler;Anders Ekbom;Mika Gissler

    (2020)
    50 Citations
  • Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology.

    Suzanne M Cadarette;Malcolm Maclure;J A Chris Delaney;Heather J Whitaker;Heather J Whitaker

    (2021)
    47 Citations
  • Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials.

    John D. Seeger;Kourtney J. Davis;Michelle R. Iannacone;Wei Zhou

    (2020)
    41 Citations
  • How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias

    Robert W. Platt;Robert W. Platt;Robert W. Platt;Richard Platt;Jeffrey S. Brown;David A. Henry;David A. Henry

    (2020)
    38 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA, exploring related online degrees and career pathways can provide valuable alternatives and enhancements to traditional medical training. Many students consider an lpn accelerated program to quickly enter the healthcare workforce as Licensed Practical Nurses, offering hands-on patient care experience in a shorter timeframe.

Advancing into research or academia is also possible through affordable options like the phd nursing programs, which prepare graduates for leadership roles in nursing education and healthcare innovation.

For those interested in the administrative side of healthcare, enrolling in medical billing and coding schools that accept financial aid offers an accessible route to stable, well-paying jobs critical to medical practice management.

Additionally, a background in biology opens a diverse range of well-paying options in the health and science sectors. Explore potential jobs with biology degree to find paths that complement or serve as an alternative to a medical career.

Best Scientists Contributing to This Journal